Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor, 43400, UPM, Malaysia.
Department of Veterinary Laboratory Diagnosis, Faculty of Veterinary Medicine, Universiti Putra Malaysia, Serdang, Selangor, 43400, UPM, Malaysia.
Nanomedicine (Lond). 2020 Mar;15(6):547-561. doi: 10.2217/nnm-2019-0178. Epub 2020 Feb 17.
To prepare, physicochemically characterize and determine the anticancer effects of palladium-doped magnesia (Pd/MgO) nanoparticles. Pd/MgO nanoparticles were prepared by the co-precipitation method from the aqueous solution of Mg(NO).6HO using KCO and the impregnation of MgO into palladium acetylacetonate. Pd/MgO nanoparticles were between 47 and 70 nm in size, cuboid in shape, and tended to form aggregates. Nanoparticles were more antiproliferative toward cancer than the normal cells. In cancer cells, Pd/MgO nanoparticles induced apoptosis by increasing caspase activities and stimulating cytochrome C release. The anticancer effects of Pd/MgO nanoparticles were accentuated by the upregulation of Bax and p53 and downregulation of Bcl-2 protein expressions. Pd/MgO nanoparticles have potential to be developed as an anticancer compound.
制备、物理化学表征并测定钯掺杂氧化镁(Pd/MgO)纳米粒子的抗癌效果。Pd/MgO 纳米粒子采用共沉淀法,由 Mg(NO)·6HO 的水溶液用 KCO 沉淀和 MgO 浸渍在乙酰丙酮钯中制得。Pd/MgO 纳米粒子的粒径在 47 至 70nm 之间,呈长方体形状,倾向于形成聚集体。纳米粒子对癌细胞的增殖抑制作用强于正常细胞。在癌细胞中,Pd/MgO 纳米粒子通过增加半胱氨酸天冬氨酸蛋白酶(caspase)的活性和刺激细胞色素 C 的释放诱导细胞凋亡。Pd/MgO 纳米粒子的抗癌效果通过上调 Bax 和 p53 蛋白表达以及下调 Bcl-2 蛋白表达得到增强。Pd/MgO 纳米粒子具有开发为抗癌化合物的潜力。